# An Interventional Study to Assess the Efficacy and Safety of Buprenorphine in Korean Patients With Spinal Disorders

> **NCT01818700** · PHASE4 · COMPLETED · sponsor: **Mundipharma Korea Ltd** · enrollment: 245 (actual)

## Conditions studied

- Spinal Disorder

## Interventions

- **DRUG:** Buprenorphine

## Key facts

- **NCT ID:** NCT01818700
- **Lead sponsor:** Mundipharma Korea Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 245 (ACTUAL)
- **Last updated:** 2015-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01818700

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01818700, "An Interventional Study to Assess the Efficacy and Safety of Buprenorphine in Korean Patients With Spinal Disorders". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01818700. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*